This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Follicular Lymphoma
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The goal of this clinical research study is to learn if the combination of bendamustine hydrochloride, mitoxantrone, and rituximab can help to control follicular lymphoma. The safety of this drug combination will also be studied.

Provided treatments

  • Drug: Bendamustine
  • Drug: Mitoxantrone
  • Drug: Rituximab
Tris trial is registered with FDA with number: NCT00901927. The sponsor of the trial is M.D. Anderson Cancer Center and it is looking for 14 volunteers for the current phase.
Official trial title:
A Phase II Study of Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma